Motivational interviewing among psychiatric in‐patients with substance use disorders

Baker, Amanda; Lewin, Terry J.; Reichler, Heidi; Clancy, Richard; Carr, Vaughan J.; Garrett, Rachel; Sly, Ketrina A.; Devir, Holly; Terry, Margarett

doi:10.1034/j.1600-0447.2002.01118.x

Cited by 87 publications

(84 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Taken together, the studies reviewed here find that motivational and cognitive-behavioral interventions have yielded improved outcomes in terms of treatment attendance, 198 substance use and relapse, 74,184,186,188,[193][194][195] symptoms, 183,187 and functioning. 74,183,184,187 While not all studies have shown these benefits, [190][191][192]197 the current state of the literature supports the use of motivational and cognitive-behavioral interventions of varying lengths in people with schizophrenia and SUDs as a way to reduce substance use and improve functioning. These findings are consistent in both RCTs with majority schizophrenia samples 183,184,[186][187][188]190,198 as well as RCTs with lower percentages of individuals with schizophrenia 74,[192][193][194][195] and a partial RCT.…”

Section: Studies Comparing Methods Of Delivery Of Treatment For Sudsmentioning

confidence: 99%

See 1 more Smart Citation

The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements

Dixon

Dickerson

Bellack

et al. 2009

Schizophrenia Bulletin

690

534

View full text Add to dashboard Cite

Section: Studies Comparing Methods Of Delivery Of Treatment For Sudsmentioning

confidence: 99%

“…197,198 Baker et al 197 randomly assigned 160 psychiatric inpatients (38% schizophrenia) to receive either a MI or no intervention. The primary outcome was engagement in a specialized substance abuse treatment program during the 3-month period following inpatient admission.…”

Section: Studies Comparing Methods Of Delivery Of Treatment For Sudsmentioning

confidence: 99%

The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements

Dixon

Dickerson

Bellack

et al. 2009

Schizophrenia Bulletin

690

534

View full text Add to dashboard Cite

“…Two to four booster sessions tailored to the needs of the participants of 30–45 min took place during the first 6 months. The main elements of the sessions were derived from a publication on MI [21], but incorporated two significant adaptations to be more applicable for dual-diagnosis patients [22,23,24,25]. First, in an integrated dual-diagnosis approach, MI therapists strategically explored interactions between psychosis and substance use, capitalizing on the effects of recent symptoms to help patients to identify a link between cannabis use and psychotic symptoms.…”

Section: Methodsmentioning

confidence: 99%

Motivational Intervention to Reduce Cannabis Use in Young People with Psychosis: A Randomized Controlled Trial

Bonsack¹,

Manetti²,

Favrod³

et al. 2011

Psychother Psychosom

View full text Add to dashboard Cite

Background: Cannabis use has a negative impact on psychosis. Studies are needed to explore the efficacy of psychological interventions to reduce cannabis use in psychosis. Our aim is to study the efficacy of a specific motivational intervention on young cannabis users suffering from psychosis. Methods: Participants (aged less than 35 years) were randomly assigned to treatment as usual (TAU) alone, or treatment as usual plus motivational intervention (MI + TAU). TAU was comprehensive and included case management, early intervention and mobile team when needed. Assessments were completed at baseline and at 3, 6 and12 months follow-up. Results: Sixty-two participants (32 TAU and 30 MI + TAU) were included in the study. Cannabis use decreased in both groups at follow-up. Participants who received MI in addition to TAU displayed both a greater reduction in number of joints smoked per week and greater confidence to change cannabis use at 3 and 6 months follow-up, but differences between groups were nonsignificant at 12 months. Conclusions: MI is well accepted by patients suffering from psychosis and has a short-term impact on cannabis use when added to standard care. However, the differential effect was not maintained at 1-year follow-up. MI appears to be a useful active component to reduce cannabis use which should be integrated in routine clinical practice.

show abstract

“…These trials include studies of the effects of motivational interviewing on drug use outcomes among inpatients and outpatients entering community-based treatment (74), on attrition among individuals on a waiting list for publicly funded drug treatment (75), on treatment entry among intravenous drug users (76), and on engagement in a specialized substance misuse program among psychiatric inpatients (77). The mixed results of these studies and of smaller pilot studies in other populations suggest that single-session motivational interviewing may not greatly enhance engagement or outcome in general populations of illicit drug users.…”

Section: Motivational Interviewingmentioning

confidence: 99%

Behavioral Therapies for Drug Abuse

Carroll

Onken

2007

FOC

View full text Add to dashboard Cite

The past three decades have been marked by tremendous progress in behavioral therapies for drug abuse and dependence, as well as advances in the conceptualization of approaches to development of behavioral therapies. Cognitive behavior therapy, contingency management, couples and family therapy, and a variety of other types of behavioral treatment have been shown to be potent interventions for several forms of drug addiction, and scientific progress has also been greatly facilitated by the articulation of a systematic approach to the development, evaluation, and dissemination of behavioral therapies. The authors review recent progress in strategies for the development of behavioral therapies for drug and alcohol abuse and dependence and discuss the range of effective behavioral therapies that are currently available.Before the advent of research on treatments derived from operant and classic behaviorism, there was little indication that any form of psychosocial treatment was effective for any type of mental disorder (1-3). Research on behavioral therapies flourished with the adoption of the technology model (4, 5), which sought to systematize these therapies and the experimental methods through which they could be evaluated to achieve a level of methodological rigor on a par with the standards for pharmacological research (6,7). By the mid to late 1980s, there were a number of behavioral treatments that had been shown to be efficacious in the treatment of a variety of mental disorders, including depressive, panic, and obsessive-compulsive disorders. However, the methodological rigor and specificity that were characteristic of these studies were not yet apparent in drug abuse treatment studies, with a few exceptions (8). Although behavioral approaches were universally available in drug abuse treatment programs by the late 1980s (9), there was continued pessimism in the field regarding the efficacy of behavioral therapies for drug use disorders (10, 11).In the early 1990s, studies in which behavioral therapies, therapist training, study populations, and objective outcome measures were carefully specified and in which participants were randomly assigned to experimental and control or comparison conditions began to appear more frequently in the drug abuse treatment literature. The technology model facilitated the identification of effective behavioral treatments for substance use disorders as it enhanced the internal validity and replicability of research on behavioral therapies. However, the technology model also had the unanticipated effect of restricting the development of novel therapies. The stringent methodological requirements associated with the technology model (e.g., requiring investigators to have fully developed treatment manuals, therapist training protocols, and fidelity rating procedures) limited the therapies eligible for efficacy evaluation to those already developed for drug abuse and to those which could easily be adapted from other areas (e.g., alcohol and depression treatments). This res...

show abstract

Motivational interviewing among psychiatric in‐patients with substance use disorders

Abstract: A different approach to treatment is recommended, including early intervention among cannabis users.

Cited by 87 publications

References 22 publications

The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements

The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements

Motivational Intervention to Reduce Cannabis Use in Young People with Psychosis: A Randomized Controlled Trial

Behavioral Therapies for Drug Abuse

Contact Info

Product

Resources

About